Fecal transplant to prevent infections in severe pancreatitis
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether a fecal microbiota transplant (FMT) can help prevent infections in people with moderately severe or severe acute pancreatitis. You may qualify if you are between 18 and 75, have had pancreatitis for 15 to 21 days, and already have a feeding tube in place.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old
- You have moderately severe or severe acute pancreatitis (with a CT score over 4)
- Your pancreatitis started 15 to 21 days ago
- You already have a nasojejunal (feeding) tube in place
- You have no active infections or conditions that would make the transplant unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a fecal transplant (transferring healthy gut bacteria from a donor) can help people with severe acute pancreatitis. It is for adults who are about 2 weeks past the onset of the disease and have started to recover but still have fluid buildup in the pancreas.
This study tests whether taking a specific friendly bacterium (Bifidobacterium longum) can help people with moderate-to-severe acute pancreatitis recover faster. Participants will either receive the bacterium or a placebo (inactive pill) for the first few days of treatment.
This study tests whether transferring healthy bacteria from donor stool (FMT) into your gut can help control severe diarrhea after total pancreas removal. It may offer a new option when standard treatments haven't worked.
This study tests if giving patients a stool transplant (also called FMT) in capsules along with their first chemotherapy can help treat advanced pancreatic cancer that cannot be removed by surgery.
This trial tests if a fecal microbiota transplant (FMT) can improve survival and recovery in ICU patients with sepsis. FMT involves transferring healthy donor bacteria into your gut to help fight severe infection.
This trial tests whether a fecal microbiota transplant (FMT)—transferring healthy gut bacteria from a donor to your digestive system—can help critically ill patients tolerate food and nutrition delivered through a feeding tube. The goal is to restore gut function and improve recovery in the ICU.
Hear when a new Acute Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.